{
    "root": "30b6f043-d418-812c-e063-6294a90ad442",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Doxazosin",
    "value": "20250319",
    "ingredients": [
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "SODIUM LAURYL SULFATE",
            "code": "368GB5141J"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "DOXAZOSIN MESYLATE",
            "code": "86P6PQK0MU"
        }
    ],
    "indications": "doxazosin tablets alpha1 adrenergic antagonist indicated : signs symptoms benign prostatic hyperplasia ( bph ) treatment hypertension",
    "contraindications": "treatment bph : initiate therapy 1 mg daily . dose maybe titrated 1 2 week intervals , 8 mg daily . ( 2.2 ) treatment hypertension : initiate therapy 1 mg daily . dose may titrated needed , 16 mg daily . ( 2.3 )",
    "warningsAndPrecautions": "doxazosin tablet , usp oral contains 2 mg doxazosin 2.426 mg doxazosin mesylate , respectively . doxazosin tablets usp , 2 mg light pink pink , mottled , round biconvex scored tablets debossed '784 ' one side score line another side supplied : ndc 68071-3811-6 bottle 60 tablets child-resistant closure storage : store 20°c 25°c ( 68°f 77°f ) [ usp controlled room temperature ] .",
    "adverseReactions": "doxazosin tablets contraindicated patients hypersensitivity doxazosin , quinazolines ( e.g . , prazosin , terazosin ) , components .",
    "indications_original": "Doxazosin tablets are an alpha1 adrenergic antagonist indicated for: Signs and symptoms of Benign Prostatic Hyperplasia (BPH) Treatment of Hypertension",
    "contraindications_original": "For the treatment of BPH: Initiate therapy at 1 mg once daily. Dose maybe titrated at 1 to 2 week intervals, up to 8 mg once daily.( 2.2 ) For the treatment hypertension: Initiate therapy at 1 mg once daily. Dose may be titrated as needed, up to 16 mg once daily. ( 2.3 )",
    "warningsAndPrecautions_original": "Each doxazosin tablet, USP for oral administration contains 2 mg of\n                  doxazosin as 2.426 mg of doxazosin mesylate, respectively.\n                  \n                  Doxazosin tablets USP, 2 mg are light pink to pink, mottled, round biconvex scored tablets\n                  debossed with '784' on one side and score line on another side and are supplied as:\n                  NDC 68071-3811-6 in bottle of 60 tablets with child-resistant closure\n                  \n                  \n                     Storage:\n                  \n                  Store at 20°C to 25°C (68°F to 77°F) [See USP Controlled Room Temperature].",
    "adverseReactions_original": "The use of doxazosin tablets is contraindicated in patients with a hypersensitivity to doxazosin, other quinazolines (e.g., prazosin, terazosin), or any of its components."
}